US 10883107
Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
granted A61KA61K31/58A61K31/585
Quick answer
US patent 10883107 (Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/58, A61K31/585, A61K31/7088, A61K9/5123